Pathology of atherosclerosis and stenting.

[1]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[2]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[3]  Shmuel Einav,et al.  A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps , 2006, Proceedings of the National Academy of Sciences.

[4]  M. Hammer,et al.  Safety, Feasibility, and Short-Term Follow-Up of Drug-Eluting Stent Placement in the Intracranial and Extracranial Circulation , 2006, Stroke.

[5]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[6]  F. Grosveld,et al.  Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress , 2006, Circulation.

[7]  M. Knauth,et al.  Late in-stent thrombosis following carotid angioplasty and stenting , 2006, Neurology.

[8]  Jonathan H. Gillard,et al.  How Critical Is Fibrous Cap Thickness to Carotid Plaque Stability?: A Flow–Plaque Interaction Model , 2006, Stroke.

[9]  B. Lal,et al.  Management of carotid restenosis. , 2006, The Journal of cardiovascular surgery.

[10]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[11]  E. Dooley.  National Institute of Neurological Disorders and Stroke , 2006 .

[12]  J. Yadav,et al.  Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-up , 2005, Stroke.

[13]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[14]  R. Virmani,et al.  Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents , 2005, Circulation.

[15]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[16]  R. Virmani,et al.  Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Elena Bonanno,et al.  Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. , 2004, JAMA.

[18]  T. Bajwa,et al.  Protected carotid-artery stenting versus endarterectomy in high-risk patients. , 2004, The New England journal of medicine.

[19]  P. Tsao,et al.  Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. , 2004, Cardiovascular research.

[20]  Amir Lerman,et al.  Adventitial vasa vasorum heterogeneity among different vascular beds. , 2004, Journal of vascular surgery.

[21]  Chun Yuan,et al.  Hemorrhage in the Atherosclerotic Carotid Plaque: A High-Resolution MRI Study , 2004, Stroke.

[22]  Giuseppe Musumeci,et al.  Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.

[23]  G. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[24]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[25]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[26]  R. Virmani,et al.  Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. , 2003, Circulation.

[27]  R. Virmani,et al.  Sirolimus-Eluting Stent Implanted in Human Coronary Artery for 16 Months , 2003 .

[28]  R. Virmani,et al.  Drug eluting stents: are human and animal studies comparable? , 2003, Heart.

[29]  Renu Virmani,et al.  Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.

[30]  P. Tsao,et al.  Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model , 2001, Circulation.

[31]  R. Virmani,et al.  Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent , 2001, Circulation.

[32]  R. Mofidi,et al.  Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease , 2001, The British journal of surgery.

[33]  Torben V. Schroeder,et al.  Ultrasonic Echolucent Carotid Plaques Predict Future Strokes , 2001, Circulation.

[34]  Renu Virmani,et al.  Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.

[35]  B. Lal,et al.  In-stent restenosis after carotid angioplasty-stenting: incidence and management. , 2001, Journal of vascular surgery.

[36]  Jeffrey J. Popma,et al.  Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2001, Circulation.

[37]  E. Edelman,et al.  Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. , 2000, Journal of the American College of Cardiology.

[38]  C. Yuan,et al.  Visualization of Fibrous Cap Thickness and Rupture in Human Atherosclerotic Carotid Plaque In Vivo With High-Resolution Magnetic Resonance Imaging , 2000, Circulation.

[39]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  M J Davies,et al.  Mechanisms of progression in native coronary artery disease: role of healed plaque disruption , 1999, Heart.

[41]  R. Virmani,et al.  Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.

[42]  F. Aydın.  Do human intracranial arteries lack vasa vasorum? A comparative immunohistochemical study of intracranial and systemic arteries , 1998, Acta Neuropathologica.

[43]  M Henry,et al.  Current global status of carotid artery stent placement. , 1998, Catheterization and cardiovascular diagnosis.

[44]  M. Hadamitzky,et al.  Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.

[45]  R. Virmani,et al.  Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.

[46]  E J Topol,et al.  Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. , 1997, Journal of the American College of Cardiology.

[47]  M. Leon,et al.  Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. , 1996, Circulation.

[48]  R. Virmani,et al.  Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. , 1996, Journal of vascular surgery.

[49]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[50]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[51]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[52]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[53]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[54]  Thomas J. Ryan,et al.  Guidelines for Percutaneous Transluminal Coronary Angioplasty A Report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) , 1993, Circulation.

[55]  E. Edelman,et al.  Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. , 1993, Circulation.

[56]  R. Kamm,et al.  Distribution of Circumferential Stress in Ruptured and Stable Atherosclerotic Lesions A Structural Analysis With Histopathological Correlation , 1993, Circulation.

[57]  W. Baxley,et al.  Vascular pathology of balloon-expandable flexible coil stents in humans. , 1992, Journal of the American College of Cardiology.

[58]  L. Wilkins.  Carotid Surgery Versus Medical Therapy in Asymptomatic Carotid Stenosis , 1991, Stroke.

[59]  E. Arbustini,et al.  Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study. , 1991, The American journal of cardiology.

[60]  R. Califf,et al.  Clinical trials of restenosis after coronary angioplasty. , 1991, Circulation.

[61]  N. Bornstein,et al.  Clinical significance of carotid plaque hemorrhage. , 1990, Archives of neurology.

[62]  W. Roberts,et al.  Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. , 1989, Circulation.

[63]  D. Ku,et al.  Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.

[64]  F. Loop,et al.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.

[65]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[66]  A. Imparato.  The carotid bifurcation plaque--a model for the study of atherosclerosis. , 1986, Journal of vascular surgery.

[67]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[68]  C. Velican.  A dissecting view on the role of the fatty streak in the pathogenesis of human atherosclerosis: culprit or bystander? , 1981, Medecine interne.

[69]  W. Siegenthaler,et al.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.

[70]  W. Couldwell,et al.  Review: Yadav JS, Wholey MH, Kuntz RE, et al: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493–1501, 2004 , 2005 .

[71]  J. Yadav.  Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. , 2004, Cleveland Clinic journal of medicine.

[72]  鈴木 健.  Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model , 2003 .

[73]  Ousa,et al.  A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .

[74]  R. Virmani,et al.  Coronary calcification: insights from sudden coronary death victims , 2000, Zeitschrift für Kardiologie.

[75]  J. Roelandt,et al.  Images in Cardiovascular Medicine , 2000 .

[76]  S. Endo,et al.  Vasa Vasorum of the Intracranial Arteries , 1998, Acta Neurochirurgica.

[77]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[78]  R. Guidoin,et al.  Carotid endarterectomy plaques: Correlations of clinical and anatomic findings , 1991, Annals of vascular surgery.

[79]  Stehbens We,et al.  Hemodynamics and atherosclerosis. , 1982, Biorheology.